Post-IPO Equity - Prenetics
Investment Firm
Overview
Prenetics is a genetic and diagnostic health testing company that helps to identify health risks with the use of DNA sequencing technology.
Announced Date
May 18, 2022
Funding Type
Post Ipo Equity
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 PAG |
Round Details and Background
Prenetics raised $120000000 on 2022-05-18 in Post-IPO Equity
Prenetics is a genetic and diagnostic health testing company that helps to identify health risks with the use of DNA sequencing technology.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 18, 2022 |  Post-IPO Equity - Prenetics | 5 | - | 120.0M |
| Oct 17, 2017 | Series B - Prenetics | 4 | - | 40.0M |
| Mar 16, 2016 | Series A - Prenetics | 5 | - | 10.0M |
| Dec 03, 2014 | Series A - Prenetics | 5 | - | 2.6M |
Recent Activity
There is no recent news or activity for this profile.